- Home
- ORGO
as 11-15-2024 4:00pm EST
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | CANTON |
| Market Cap: | 408.3M | IPO Year: | N/A |
| Target Price: | $5.33 | AVG Volume (30 days): | 572.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.17 - $4.71 | Next Earning Date: | 11-12-2024 |
| Revenue: | $455,038,000 | Revenue Growth: | 1.34% |
| Revenue Growth (this year): | 7.42% | Revenue Growth (next year): | 0.08% |
Latest Organogenesis Holdings Inc. News
ORGO Breaking Stock News: Dive into ORGO Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Organogenesis Commends Final LCDs
GuruFocus.com
4 days ago
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Motley Fool
5 days ago
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript
Zacks
5 days ago
Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates
Associated Press Finance
5 days ago
Organogenesis: Q3 Earnings Snapshot
GlobeNewswire
5 days ago
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
GlobeNewswire
5 days ago
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
GlobeNewswire
6 days ago
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Compare ORGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORGO Organogenesis Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.